Manufacturer record
Jips Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Jips Pharmaceuticals Pvt. Ltd (Punjab) were declared Not of Standard Quality between February 2022 and September 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 21JP/T-2247, Glimepiride Tablets IP 1 mg. Glimvale-1 Tablets (exp Nov 2023). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the September 2022 alert.
Records by type
2 records linked to Jips Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glimepiride Tablets IP 1 mg. Glimvale-1 Tablets | Batch 21JP/T-2247Mfg Dec 2021 · Exp Nov 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Flupentixol & Melitracen Hydrochloride Tablets | Batch 21JP/T-1669DMfg Sep 2021 · Exp Aug 2023 | MisbrandedMisbranded | RDTL GuwahatiState lab | Feb 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.